Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.
第一作者:
Carine,Domenech
第一单位:
Institute of Hematology and Oncology Pediatrics, Hospices Civils de Lyon, University Claude Bernard Lyon I, France carine.halfon-domenech@chu-lyon.fr.
作者:
医学主题词
青少年(Adolescent);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);儿童(Child);儿童, 学龄前(Child, Preschool);地塞米松(Dexamethasone);女(雌)性(Female);人类(Humans);免疫表型分型(Immunophenotyping);婴儿(Infant);婴儿, 新生(Infant, Newborn);男(雄)性(Male);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);泼尼松龙(Prednisolone);危险因素(Risk Factors);治疗结果(Treatment Outcome)
DOI
10.3324/haematol.2014.103507
PMID
24727815
发布时间
2024-05-03
- 浏览25
Haematologica
1220-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



